Jury Rejects Doctor's Claim Over Genentech Drug
Kourosh Dastgheib filed the claim in March 2003 when Lucentis, a drug used to treat the degenerative eye disease wet age-related macular degeneration, was in clinical trials.
Dastgheib claimed he made an agreement with San Francisco-based Genentech in which he would provide macular degeneration research in return for a share of the drug’s profits.
In a recent filing with...
To view the full article, register now.